###begin article-title 0
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 111 114 <span type="species:ncbi:10116">rat</span>
Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc</italic>
###xml 235 238 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16</italic>
The development and progression of liver cancer may involve abnormal changes in DNA methylation, which lead to the activation of certain proto-oncogenes, such as c-myc, as well as the inactivation of certain tumor suppressors, such as p16. Betaine, as an active methyl-donor, maintains normal DNA methylation patterns. However, there are few investigations on the protective effect of betaine in hepatocarcinogenesis.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 294 300 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 390 396 390 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 15 19 <span type="species:ncbi:10116">rats</span>
Four groups of rats were given diethylinitrosamine (DEN) and fed with AIN-93G diets supplemented with 0, 10, 20 or 40 g betaine/kg (model, 1%, 2%, and 4% betaine, respectively), while the control group, received no DEN, fed with AIN-93G diet. Eight or 15 weeks later, the expression of p16 and c-myc mRNA was examined by Real-time PCR (Q-PCR). The DNA methylation status within the p16 and c-myc promoter was analyzed using methylation-specific PCR.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 178 186 178 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &lt; 0.05</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 362 370 362 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &gt; 0.05</italic>
###xml 431 435 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 519 521 519 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 672 680 672 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &lt; 0.05</italic>
###xml 151 155 <span type="species:ncbi:10116">rats</span>
Compared with the model group, numbers and areas of glutathione S-transferase placental form (GST-p)-positive foci were decreased in the livers of the rats treated with betaine (P < 0.05). Although the frequency of p16 promoter methylation in livers of the four DEN-fed groups appeared to increase, there is no difference among these groups after 8 or 15 weeks (P > 0.05). Betaine supplementation attenuated the down-regulation of p16 and inhibited the up-regulation of c-myc induced by DEN in a dose-dependent manner (P < 0.01). Meanwhile, increases in levels of malondialdehyde (MDA) and glutathione S-transferase (GST) in model, 2% and 4% betaine groups were observed (P < 0.05). Finally, enhanced antioxidative capacity (T-AOC) was observed in both the 2% and 4% betaine groups.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 63 66 <span type="species:ncbi:10116">rat</span>
Our data suggest that betaine attenuates DEN-induced damage in rat liver and reverses DEN-induced changes in mRNA levels.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Liver cancer is one of the most common types of malignancy, especially in Asia and Africa, and it is the second most common cause of cancer death in China [1,2]. Because of the very poor prognosis, the number of death remains stubbornly high [1]. Despite the effort in advancing the treatment of this disease in recent decades, long-term therapeutic outcome in liver cancer remains poor, and the prognosis is dire. Thus, prevention appears to be the best strategy for reducing the current prevalence of the disease [3].
###end p 11
###begin p 12
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 340 346 340 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 528 534 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 632 638 632 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-myc </italic>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 793 794 793 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 804 808 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1022 1026 1022 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 1094 1098 1094 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 1187 1189 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1190 1192 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1254 1260 1254 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 1264 1268 1264 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 1358 1360 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1361 1363 1361 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1055 1063 <span type="species:ncbi:9606">patients</span>
The development of liver cancer is a multistep process of genetic alterations, involving the activation of proto-oncogenes and the inactivation of tumor suppressors [4-6], which lead to a continuous increase of uncontrolled cellular proliferation. Therefore, abnormal expression of related genes plays a crucial role in carcinogenesis. The c-myc proto-oncogene encodes a transcription factor involved in regulating cell proliferation, differentiation, and apoptosis [5,7-9]. A few studies have shown that hypomethylation of the c-myc gene promoter results in its over-expression, especially in the methyl-absent conditions [10,11]. C-myc over-expression is associated with liver cancer development by causing inappropriate gene expression which results in autonomous cellular proliferation [8,9,12]. The p16 tumor suppressor is an inhibitor of cyclin D-dependent protein kinases, and it halts the cell cycle in the G1 phase [13]. Several recent studies have revealed that extensive DNA methylation is the primary cause of p16 inactivation in liver cancer patients, and that hypermethylation of p16 occurs not only in the liver cancer but also in the pre-neoplastic liver tissue as well [14-16]. Abnormal changes in DNA methylation and mRNA expression of c-myc and p16 are, therefore, the two important stimulatory factors in the development of liver cancer [14-16].
###end p 12
###begin p 13
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 952 953 952 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 954 956 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 158 163 <span type="species:ncbi:4565">wheat</span>
###xml 165 172 <span type="species:ncbi:3562">spinach</span>
###xml 178 189 <span type="species:ncbi:3555">sugar beets</span>
###xml 894 897 <span type="species:ncbi:10116">rat</span>
There is a growing body of evidence which supports that chemoprevention is the cornerstone for precluding liver cancer [3,17]. Betaine, found particularly in wheat, spinach, and sugar beets, is an active methyl-donor. The main biochemical function of betaine is to transfer one-carbon moieties to maintain normal DNA methylation pattern in the body [18-21]. Thus, it is reasonable to propose that betaine may help to prevent liver cancer through regulating the expression of proto-oncogenes and tumor suppressors by stabling their mythylation patterns. Although some studies have suggested the role of betaine in preventing alcoholic liver diseases [18,20], the effect of betaine supplementation in preventing liver cancer has not yet to be investigated. The purpose of this study is to determine whether betaine supplementation attenuates the development of liver cancer in a well established rat model induced by diethylinitrosamine (DEN) treatment [3,17], as well as the exploration of mechanisms underlying the attenuation effect.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Animals and dietary intervention
###end title 15
###begin p 16
###xml 387 389 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 37 56 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 244 248 <span type="species:ncbi:10116">rats</span>
###xml 425 429 <span type="species:ncbi:10116">rats</span>
###xml 829 833 <span type="species:ncbi:10116">Rats</span>
Seventy pathogen-free, weanling male Sprague-Dawley rats (150 +/- 10 g) were purchased from the Animal Center of Guangdong Province, and were kept in metabolism cages with controlled temperature (23 +/- 2degreesC) and humidity (55% +/- 5). All rats were acclimated for one week on a standard AIN-93G diet, supplying 187 g/kg protein, 70 g/kg fat, 50 g/kg fiber, and 3970 kcal/kg energy [22]. After a week of acclimatization, rats were divided into five groups according to their body weights. The control group was provided with distilled water and AIN-93G diet. The four experimental groups were given 0.01% diethylinitrosamine solution (DEN; Sigma Chemical Co., St. Louis, MO) and fed AIN-93G diets supplemented with 0, 10, 20, or 40 g betaine/kg. They were designated as the model, 1%, 2%, and 4% betaine group, respectively. Rats were housed individually and had free access to food and water throughout the 15-week period. Body weight and food consumption were recorded weekly. Betaine was purchased from Cultor Ltd. (Finnsugar Bioproducts, Finland). All the animal work procedures were approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University.
###end p 16
###begin title 17
Assay of serum marker enzymes
###end title 17
###begin p 18
###xml 5 9 <span type="species:ncbi:10116">rats</span>
Five rats from each group were sacrificed by exsanguination under anesthesia after receiving the experiment diet for 8 or 15 weeks. Blood was collected by femoral artery puncture. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and Gamma glutamyl transferase (GGT) were measured by HITACHI autoanalyzer according to the standard procedures using commercially available diagnostic kits (Sigma).
###end p 18
###begin title 19
Assay of hepatic antioxidase and lipid peroxidation
###end title 19
###begin p 20
The liver tissue were rapidly removed, washed in 0.9% NaCl, kept on ice, and homogenized in ice cold isotonic Na chloride. After centrifugation, the supernatant was collected. Levels of hepatic antioxidase and lipid peroxidation, including MDA, SOD, GSH, GST, and T-AOC, were measured using corresponding diagnostic kits (Nanjing Jiancheng Bioengineering Institute, Jiangsu province, China). Protein concentrations were determined by Coomassie Blue Staining method (Nanjing Jiancheng Bioengineering Institute, Jiangsu province, China).
###end p 20
###begin title 21
Histopathology and immunohistochemistry
###end title 21
###begin p 22
###xml 509 515 <span type="species:ncbi:9986">rabbit</span>
The livers were removed and 3 slices were taken from each sublobe and fixed in 10% buffered formalin for histopathological examination. Two sections from each slice embedded in paraffin were prepared for the histopathological and immunohistochemical examinations. One section was stained with hematoxylin and eosin (H&E) and was examined under light microscopy for diagnosing liver lesions. Another section was used for Immunohistochemical staining of GST-p. The deparaffinized sections were incubated with a rabbit polyclonal anti-GST-p antibody (1:1,000 dilution, MBL, Nagoya, Japan) overnight in a humidified chamber at 4degreesC. The sections were then washed with PBS, and incubated with a correspondent secondary antibody. Subsequently, the sections were reacted with diaminobenzidine and hydrogen peroxide for 10 min. Control sections, in which the primary antibody was omitted, were treated in the same way and showed no immunostaining. Slides were examined by light microscopy, and the numbers and areas of GST-p-positive foci (>0.2 mm diameter) and the total areas of the liver sections were quantified using Scion Image (Scion Corp., Frederick, MD, USA).
###end p 22
###begin title 23
Methylation-specific PCR (MSP)
###end title 23
###begin p 24
###xml 211 225 211 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc and p16 </italic>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 508 519 507 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc were </italic>
###xml 781 792 780 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc were </italic>
###xml 907 912 906 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">were </italic>
###xml 1235 1240 1210 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc</italic>
###xml 1333 1336 1296 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16</italic>
Genomic DNA was extracted from frozen tissues using a DNeasy tissue kit (Promega, Madison, WI, America) following the manufacturer's instructions. Methylation status of the CpG islands in the promoter region of c-myc and p16 was determined by bisulfite modification and subsequent methylation-specific PCR, as previously described with some modifications [12]. Briefly, 2 mug of genomic DNA was used for bisulfite modification. MSP was performed using methyl-specific primers (Forward and reverse primer for c-myc were 5'-AAA CGA TAA GAG GCG GAT ATA TAA C-3' and 5'-ATT TTC CAA CTC AAA AAT CTA ATC G-3'. Forward and reverse primer for P16 were 5'-TAG TAT TGT ATT AGG TAG GGG CGC-3' and 5'-TAT CGA TAA CCC GAA AAA CGT T-3'.) and unmethyl-specific primers (U forward and reverse for c-myc were 5'-ATG ATA AGA GGT GGA TAT ATA ATG T-3' and 5'-TTT TCC AAC TCA AAA ATC TAA TCA C-3'. U forward and reverse for P16 were 5'-AGT ATT GTA TTA GGT AGG GGT GTG G-3' and 5'-ACC TAT CAA TAA CCC AAA AAA CAT T-3'). The PCR conditions were as follows: one cycle at 94degreesC for 5 min, 40 cycles at 94degreesC for 30 s, an annealing step for 30 s at the appropriate temperature (59.5degreesC and 53.0degreesC for primers to methylated and unmethylated c-myc, respectively, and 62.0degreesC and 60.0degreesC for primers to methylated and unmethylated p16), extension at 72degreesC for 30 s, and a final extension step at 72degreesC for 10 min. Final PCR products were separated by electrophoresis in a 2% agarose gel and visualized under UV illumination.
###end p 24
###begin title 25
Real time PCR (Q-PCR) for c-myc and p16
###end title 25
###begin p 26
###xml 246 252 245 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 256 260 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 425 429 424 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 592 598 591 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 1041 1043 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
Total RNA was extracted from liver tissues using RNAiso Reagent (Takara Bio Co., Ltd., Kyoto, Japan). Complementary DNA (cDNA) was synthesized from 1 mug of purified total RNA using the first strand cDNA synthesis Kit (ToYoBo, Osaka, Japan). The c-myc and p16 genes were co-amplified with a fragment of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene, which served as an internal standard. Primer sequences for the p16 gene (GenBank accession ) were: 5'-TGC AGA TAG ACT AGC CAG GGC-3' (Forward Primer) and 5'-CTC GCA GTT CGA ATC TGC AC-3' (Reverse Primer). Primer sequences for the c-myc gene (GenBank accession ) were 5'-GCT CTC CGT CCT ATG TTG CG-3' (Forward Primer) and 5'-TCG GAG ACC AGT TTG GCA G-3' (Reverse Primer). Primers for the GAPDH gene (GenBank accession ) were 5'-ACC AAC TGC TTA GCC CCC C-3' (Forward Primer) and 5'-GCA TGT CAG ATC CAC AAC GG-3' (Reverse Primer). Specification of each pair of primers was tested by randomly sequencing three clones, and further confirmed by the melting curve analysis using Q-PCR [23]. The amplification efficiency of each pair of primers was tested by constructing corresponding plasmid. Only primers with similar amplification efficiency were used in this experiment. Q-PCR was conducted by amplifying 1.0 mul of diluted cDNA with the SYBR Green Real-time PCR Master Mix kit (TOYOBO Company, Japan) on the ABI 7500 sequence detection system (Perkin-Elmer/PE Applied Biosystems). The cycling conditions of forty cycles of PCR were 94degreesC/20 s, 58degreesC/20 s, 72degreesC/20 s. The amount of specific mRNA was quantified by determining the point at which the fluorescence accumulation entered the exponential phase (Ct), and the Ct ratio of the target gene to GAPDH was calculated for each sample. Each sample was run in triplet repeat and all the PCR data were analyzed with the ABI 7500 system software 4.0 version.
###end p 26
###begin title 27
Statistical analysis
###end title 27
###begin p 28
###xml 301 310 299 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &lt; 0.05 </italic>
All mean values are reported as the mean +/- SD. Data were analyzed using a one-way analysis of variance, followed by least significant difference (LSD) test. Chi Square test and Fisher's exact test were used to compare the incidence of irregular DNA methylation. The level of significance was set at P < 0.05 in all cases. All statistical analyses were performed using SPSS software (Version 11.0) (SPSS Inc, Chicago, IL).
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
General observations
###end title 30
###begin p 31
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 376 379 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 412 415 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 471 474 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 86 90 <span type="species:ncbi:10116">rats</span>
###xml 271 275 <span type="species:ncbi:10116">rats</span>
###xml 355 358 <span type="species:ncbi:10116">rat</span>
###xml 425 428 <span type="species:ncbi:10116">rat</span>
Rats in the control group grew well throughout the entire experiment period. Although rats in other four groups showed fluffy fur, glassy eyes and decreased movement, the food intake and weight gain showed no significant difference among the groups (data not shown). Two rats of the 2% betaine group died during the 4th week. In the 4% betaine group, one rat died during the 5th week and another one during the 6th week. One rat died in the 1% betaine group during the 15th week.
###end p 31
###begin title 32
###xml 73 76 <span type="species:ncbi:10116">Rat</span>
Histopathological Changes and immunohistochemical expression of GST-P in Rat Livers
###end title 32
###begin p 33
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 165 168 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
In the 8th week, apomorphosis, necrosis, and accrementition were apparent in the liver slices of the model, 1%, 2%, and 4% betaine groups (date not shown). In the 15th week, widespread malignant cells were observed in the four groups receiving DEN, whereas the model group showed most severely malignancy (Fig. 1).
###end p 33
###begin p 34
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histopathological changes in rat livers</bold>
###xml 29 32 <span type="species:ncbi:10116">rat</span>
###xml 51 55 <span type="species:ncbi:10116">rats</span>
Histopathological changes in rat livers. Livers of rats in model, 1%, 2%, and 4% betaine groups: widespread malignant cells were observed, the model group showed most severe malignancy. Original magnification: 10 x 40. A: Control; B: Model; C: 1% betaine; D: 2% betaine; E: 4% betaine.
###end p 34
###begin p 35
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 413 415 413 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 561 569 561 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &lt; 0.05</italic>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 687 691 <span type="species:ncbi:10116">rats</span>
Since the abnormalities in the expression of GST-p, a cell proliferation biomarker, play a critical role in the development of liver cancer, we assessed the expression of GST-p in liver cells. Numbers and areas of GST-p-positive foci in the mode group were significantly increased when compared with the control group (Fig. 2). Although there was not statistical difference among the four betaine-treated groups (P > 0.05), betaine supplementation was shown to decrease numbers and areas of GST-p-positive foci in the developing of liver cancer induced by DEN (P < 0.05) (Fig. 3). These observations collectively suggest that betaine decreases the process of hepatocellular carcinoma in rats induced by DEN.
###end p 35
###begin p 36
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunohistochemical staining of GST-p</bold>
Immunohistochemical staining of GST-p. Control liver tissue: with weakly positive GST-p; Model liver tissue: with strongly positive GST-p expression. 1%, 2%, and 4%betaine groups showed liver tissues with positive GST-p expression. Original magnification: 10 x 40. A: Control; B: Model; C: 1% betaine; D: 2% betaine; E: 4% betaine.
###end p 36
###begin p 37
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The numbers and areas of GST-p-positive foci in different groups of rat livers</bold>
###xml 178 180 176 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 68 71 <span type="species:ncbi:10116">rat</span>
The numbers and areas of GST-p-positive foci in different groups of rat livers. Data are means +/- SD. Different letter (such as "a" versus "b") on the top of each bar indicates P < 0.05 between them. A: Numbers; B: Areas.
###end p 37
###begin title 38
Contents of ALT, AST, ALP, GGT
###end title 38
###begin p 39
###xml 101 110 101 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &lt; 0.001</italic>
###xml 245 253 245 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &lt; 0.05</italic>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
We observed marked increases in the levels of ALT, AST, ALP and GGT in the four groups received DEN (P < 0.001). However, AST and ALT levels after 15 weeks in the 1% betaine group were shown to be deceased compared with that in the model group (P < 0.05) (Table 1).
###end p 39
###begin p 40
Levels Of ALT, AST, ALT and GGT
###end p 40
###begin p 41
###xml 34 36 34 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#9650;</sup>
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p &lt; 0.05</italic>
*Compared with the control group, p < 0.05. ▲Compared with the model group, p < 0.05.
###end p 41
###begin title 42
Hepatic Antioxidase and Lipid Peroxidation
###end title 42
###begin p 43
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &lt; 0.05</italic>
###xml 173 181 173 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &lt; 0.05</italic>
###xml 262 270 262 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &lt; 0.05</italic>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
After 8 week, both MDA and GST levels increased in the model, 2% and 4% betaine groups (P < 0.05), but decreased in the 1% betaine group when compared with the model group (P < 0.05). T-AOC levels were also shown to be increased in the 2% and 4% betaine groups (P < 0.05) (Table 2) after 8 week.
###end p 43
###begin p 44
Hepatic antioxidase and lipid peroxidation
###end p 44
###begin p 45
###xml 34 36 34 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#9650;</sup>
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p &lt; 0.05</italic>
*Compared with the control group, p < 0.05; ▲Compared with the model group, p < 0.05.
###end p 45
###begin title 46
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc</italic>
DNA methylation status of c-myc
###end title 46
###begin p 47
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 240 248 240 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &gt; 0.05</italic>
###xml 264 272 264 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &gt; 0.05</italic>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 4 8 <span type="species:ncbi:10116">rats</span>
All rats of each group were evaluated for aberrant promoter methylation of the c-myc gene using MSP. Methylated and unmethylated c-myc alleles were shown in Fig 4. There was no statistically significant difference among the groups after 8 (P > 0.05) and 15 weeks (P > 0.05) (Table 3).
###end p 47
###begin p 48
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
The methylation status of c-myc in the 8th and 15th week
###end p 48
###begin p 49
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 141 152 141 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(P &gt; 0.05) </italic>
###xml 165 175 165 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(P &gt; 0.05)</italic>
M: methylated; U:unmethylated. The methylation status of c-myc in each group didn't show statistically significant differences after 8 weeks (P > 0.05) and 15 weeks (P > 0.05).
###end p 49
###begin p 50
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DNA methylation status of the <italic>c-myc </italic>promoter region</bold>
DNA methylation status of the c-myc promoter region. U: unmethylated, 103 bp; M: methylated, 100 bp.
###end p 50
###begin title 51
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P16 </italic>
P16 Methylation
###end title 51
###begin p 52
###xml 4 5 4 5 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 250 258 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P &gt; 0.05</italic>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
Fig 5 shows the results of p16 promoter DNA methylation by MSP. Although the frequency of promoter methylation for p16 in livers of the four DEN-fed groups appeared to increase, we didn't see a difference among these four groups after 8 or 15 weeks (P > 0.05) (Table 4).
###end p 52
###begin p 53
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DNA methylation status of the <italic>p16 </italic>gene promoter region</bold>
DNA methylation status of the p16 gene promoter region. U: unmethylated, 151 bp; M: methylated, 153 bp.
###end p 53
###begin p 54
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
The methylation status of p16 in the 8th and 15th week
###end p 54
###begin p 55
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 139 150 139 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(P &gt; 0.05) </italic>
###xml 163 173 163 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(P &gt; 0.05)</italic>
M: methylated; U:unmethylated. The methylation status of p16 in each group didn't show statistically significant differences after 8 weeks (P > 0.05) and 15 weeks (P > 0.05).
###end p 55
###begin title 56
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
Effects of betaine on c-myc and p16 mRNA expression
###end title 56
###begin p 57
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 465 471 465 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 564 570 564 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 631 633 631 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 715 730 715 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 expression </italic>
###xml 773 775 773 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 77 81 <span type="species:ncbi:10116">rats</span>
Using Q-PCR, gene-specific mRNA expression was quantified in the livers from rats taking DEN solution (model, 1%, 2%, and 4% of betaine) for 15 weeks and results were expressed relative to the number of GAPDH transcripts. The mRNA levels of p16 and c-myc in livers of the control group were set at 1.00, and mRNA expressions of the four experimental groups were evaluated by its relative ratio. As shown in Fig 6 and Fig 7, DEN treatment enhanced the expression of c-myc after both 8 and 15 weeks, while betaine supplementation decreased the stimulatory effect on c-myc expression by DEN in a dose-dependent manner after 15 weeks (P < 0.01). On the contrary, betaine supplementation enhanced the down-regulation of p16 expression induced by DEN in a dose-dependent manner (P < 0.01).
###end p 57
###begin p 58
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantitation of mRNA levels of <italic>c-myc </italic>in the liver at week 8 and 15 in model, 1%, 2% and 4% betaine groups</bold>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 268 270 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 293 295 293 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 358 364 358 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 427 429 427 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 536 538 534 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Quantitation of mRNA levels of c-myc in the liver at week 8 and 15 in model, 1%, 2% and 4% betaine groups. Results were expressed relative to the control group. Compared with the control group, the mRNA levels of c-myc in the model group were increased after 8 weeks (P < 0.001) and 15 weeks (P < 0.001). Betaine significantly decreased the up-regulation of c-myc expression induced by DEN in a concentration-dependent manner (P < 0.01). Data are means +/- SD. Different letter (such as "a" versus "b") on the top of each bar indicates P < 0.05 between them.
###end p 58
###begin p 59
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantitation of mRNA levels of <italic>p16 </italic>in livers at week 8 and 15 in model, 1%, 2% and 4% betaine groups</bold>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 228 230 228 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 253 255 253 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 349 351 349 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 458 460 456 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Quantitation of mRNA levels of p16 in livers at week 8 and 15 in model, 1%, 2% and 4% betaine groups. Results were expressed relative to the control group. The mRNA levels of p16 in the model group were decreased after 8 weeks (P < 0.001) and 15 weeks (P < 0.001) and betaine increased the down-regulation induced by DEN in a dose-dependent manner (P < 0.01). Data are means +/- SD. Different letter (such as "a" versus "b") on the top of each bar indicates P < 0.05 between them.
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 124 128 <span type="species:ncbi:10116">rats</span>
###xml 186 204 <span type="species:ncbi:10116">Sprague-Dawley rat</span>
###xml 772 776 <span type="species:ncbi:10116">rats</span>
Diethylinitrosamine is a powerful hepatocarcinogen known to induce cancer in experimental animals [3,17]. In our study, all rats given DEN developed the liver cancer, demonstrating that Sprague-Dawley rat is a suitable model in studying DEN induced liver cancer. DEN treatment was shown to significantly increase both numbers and areas of GST-p-positive foci (model group), while betaine supplementation (in all the three experimental groups) attenuated the effect of DEN. Although there was no statistical difference among the betaine treatment groups, betaine supplementation decreased the increase of GST-p in the developing of liver cancer induced by DEN. Collectively, these observations suggested that betaine can decrease the process of hepatocellular carcinoma in rats induced by DEN.
###end p 61
###begin p 62
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 581 582 581 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 996 1001 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1097 1099 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 249 255 <span type="species:ncbi:9606">humans</span>
###xml 1151 1154 <span type="species:ncbi:10116">rat</span>
###xml 1375 1378 <span type="species:ncbi:10116">rat</span>
There is a strong correlation between oxidative stress and the occurrence of liver cancer [24,25]. Enhanced lipid peroxidation and/or a dysregulated antioxidant system have been associated with liver cancer in both experimental animal models and in humans [24,25]. Betaine acts as a methyl donor by participating in the generation of methionine from homocysteine through the catalytic action of betaine-homocysteine methyltransferase. Previous studies have shown that betaine is effective at preventing a variety of toxic injuries to the liver, such as those induced by niacin, CCl4, and hyperosmolarity [26-28]. Betaine appears to confer this protection by reducing peroxidation in the liver [28]. In our study, we found that MDA and GST levels decreased in the 1% betaine group when compared with the model group. Although the increase in the dosage of betaine did not increase the antioxidation activity in a dose-dependent manner, our observations are consistent with the suggestion by Hayes et al. that betaine is safe and nontoxic [29]. Betaine metabolism occurs predominantly in the liver [20], and DEN is able to generate acute damages in the rat liver [30]. We found that T-AOC level was higher in the 2% and 4% betaine groups than that in either the control or the model group. These observations suggest that betaine may increase the antioxidation activity of the rat hepatocytes.
###end p 62
###begin p 63
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
Carcinogenesis is a multi-stage process characterized by continuous changes in genotypes and phenotypes [4,5,7-14]. In the same way, hepatocarcinogenesis is a multistep process involving genetic and epigenetic alterations of various oncogenes, proto-oncogenes, and growth factors, as well as tumor suppressors [4,5,7-14]. DNA methylation is a fundamental epigenetic process that regulates not only gene transcription but also histone acetylation and chromosomal stability [11,13,14,31]. DNA methylation, primarily at the C5 position of cytosine, affects gene expression during many biological processes, such as differentiation, genomic imprinting, DNA mutation, and DNA repair [11,13,14,31].
###end p 63
###begin p 64
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 162 167 <span type="species:ncbi:9606">human</span>
Aberrant methylation of cytosine residues at CpG dinucleotides in DNA is one of the most common epigenetic changes observed in the development and progression of human cancers, including that of the liver [31]. Shen et al. have shown that environmental factors may influence the frequency and concomitant degree of hypermethylation in multiple genes in liver cancer [32]. They have also demonstrated that oxidative damage can directly affect DNA methylation status [32].
###end p 64
###begin p 65
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16</italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc</italic>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
DNA methylation has been recognized as an important factor in the inactivation of tumor suppressors, such as p16, and in the activation of proto-oncogenes such as c-myc. DNA hypermethylation, usually occurring at CpG islands in promoters, is a major epigenetic mechanism in the silencing of gene expression [15,16]. Aberrant methylation of CpG islands in the promoter region of p16 is associated with transcriptional inactivation of p16 itself. Methylation at CpG islands may inhibit gene expression, either directly by interrupting the binding of transcription activators to the promoter, or indirectly through methyl-binding proteins (MBPs) [15,16,32]. MBPs bind preferentially to methylated DNA sequences of a promoter and thereby silence its transcription by either competing with transcription activators for the binding sites, or by promoting histone deacetylation and chromatin remodeling that prevent transcription factors from binding to the DNA [32]. C5 cytosine methylation at CpG sites not only significantly increases carcinogen-DNA adduct formation at CpG sites, but also affects carcinogen-DNA adduct formation at surrounding sequences [33].
###end p 65
###begin p 66
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16</italic>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 608 611 608 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16</italic>
###xml 633 637 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 662 666 662 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 468 472 <span type="species:ncbi:10116">rats</span>
###xml 499 503 <span type="species:ncbi:10116">rats</span>
###xml 683 686 <span type="species:ncbi:10116">rat</span>
The p16 gene encodes an inhibitor of cyclin D-dependent protein kinases. It reduces enzymatic activity of cyclin/cdk complexes, leading to aberrant phosphorylation of another tumor suppressor Rb, which, in turn, accelerates cell proliferation [34,35]. When hypermethylation occurs in the CpG islands within the 5' flanking region of p16, its transcription is inhibited, which is a common marker of the early carcinogenic event [34,35]. We found that compared with the rats in the control group, the rats in all the four DEN treated groups showed higher rates of hypermethylation and decreased mRNA levels of p16. This indicates that p16 hypermethylation induces p16 silencing in the rat liver cells, correlating with the development of liver cancer.
###end p 66
###begin p 67
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-myc </italic>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
C-myc is an important regulator of various cellular processes, and has been shown to drive quiescent cells into the S phase in the absence of other mitogenic signals [5,7,12]. Diverse cellular functions of the c-myc oncogene are closely tied to its ability to either activate or repress gene transcription. Recently, a few studies have indicated that hypomethylation of the c-myc gene results in its over-expression in hepatocarcinogenesis, especially in the methyl-absent conditions [10,11].
###end p 67
###begin p 68
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
As a methyl donor, betaine is proposed to play a role in homocysteine metabolism [36], and provides methyl groups for the synthesis of S-adenosylmethionine (SAM) [18,19,37]. The requirement of SAM for cellular metabolism normally exceeds what mammals obtain through their diets. Insufficiency in SAM can be prevented through the methionine cycle that metabolizes 5'-methyltetrahydrofolate (5'-methyl-THF) and betaine [38]. In the methionine cycle, both an increase in s-adenosyl-l-homocysteine (SAH) level and a decrease in the SAM:SAH ratio are known to reduce DNA methyltransferase activity and inhibit transmethylation reactions [18,19,37,39,42,43]. Betaine is effective at increasing the SAM:SAH ratio and supposed to maintain normal DNA methylation patterns [40].
###end p 68
###begin p 69
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 187 191 <span type="species:ncbi:10116">rats</span>
In the present study, we have, however, found that betaine had no effect on methylation of p16 or c-myc by MSP and there were no differences in c-myc methylation among the five groups of rats. It may be necessary to use more sensitive methods to quantify methylation levels. It is also possible that betaine plays a key role in maintaining complete organism-wide methylation, not the methylation of a few, specific genes. This requires further investigations.
###end p 69
###begin p 70
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 665 666 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 669 671 669 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">10</sup>
###xml 708 709 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 712 714 712 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">10</sup>
###xml 681 686 <span type="species:ncbi:42554">tetra</span>
###xml 725 730 <span type="species:ncbi:42554">tetra</span>
There are two re-methylation pathways utilized by betaine and 5'-methyl-THF, which are interrelated in the methionine cycle. The limitation of one pathway increases re-methylation via the other pathway [41]. Folic acid is the precursor of 5'-methyl-THF, and it also takes part in certain important procedures like the synthesis and reparation of DNA and RNA in addition to its effects on regulating DNA methylation. Having efficient methyl groups with three active methyls, betaine may reduce the consumption of folic acid in the methionine cycle, and it may play some part in maintaining DNA stability [42,43]. After metabolism, betaine molecules are degraded to N5, N10-methenyl-tetra-hydrofolic acid and N5, N10-methylene-tetra-hydrofolic acid, which can be reused in the synthesis of purine and thymine. These actions can regulate the mRNA expression.
###end p 70
###begin p 71
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 319 325 319 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 329 332 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16</italic>
We found c-myc over-expression in the four DEN treated groups, while the enhancement was inhibited by betaine in a dose-dependent manner. Meanwhile, betaine supplementation also enhanced the down-regulation of p16 induced by DEN in a dose-dependent manner. These results suggest that betaine regulates transcription of c-myc and p16, which leads to the stability of the two genes in the body and attenuate the carcinogenic effects of DEN.
###end p 71
###begin title 72
Conclusion
###end title 72
###begin p 73
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc</italic>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p16 </italic>
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-myc </italic>
###xml 86 89 <span type="species:ncbi:10116">rat</span>
###xml 220 223 <span type="species:ncbi:10116">rat</span>
DEN induces disequilibrium in the lipid peroxidation and antioxidation systems of the rat liver, and alters mRNA expression levels of both p16 and c-myc. Betaine supplementation attenuates carcinogenic effects of DEN in rat livers and reverses DEN-induced changes in p16 and c-myc mRNA expression.
###end p 73
###begin title 74
Abbreviations
###end title 74
###begin p 75
DEN: diethylinitrosamine; SAM: S-adenosylmethionine; ALT: alanine transaminase; AST: aspartate transaminase; ALP: alkaline phosphatase; GGT: gamma-glutamyltransferase; MDA: malondialdehyde; SOD: superoxide dismutase; GSH: reduced glutathione; GST: glutathione S-transferase; T-AOC: total antioxidative capacity; MSP: Methylation-specific PCR; Q-PCR: Real time PCR; MBPs: methyl-binding proteins; SAH: s-adenosyl-l-homocysteine; 5'-methyl-THF: 5'-methyltetrahydrofolate.
###end p 75
###begin title 76
Competing interests
###end title 76
###begin p 77
The authors declare that they have no competing interests.
###end p 77
###begin title 78
Authors' contributions
###end title 78
###begin p 79
YPD carried out the animal studies and the methylation experiments, and drafted the manuscript. JSP performed data analysis and participated in the design of the study. AS carried out the immunoassays. ZHT carried out the realtime PCR experiments. WHL participated in the design and coordination of the study. HLZ conceived of the study and revised the manuscript. All authors read and approved the final manuscript.
###end p 79
###begin title 80
Pre-publication history
###end title 80
###begin p 81
The pre-publication history for this paper can be accessed here:
###end p 81
###begin p 82

###end p 82
###begin title 83
Acknowledgements
###end title 83
###begin p 84
Tianru Jin is acknowledged for revising the manuscript and giving many useful advices. This work was supported by National Natural Science Foundation of China (No. 30872099, No. 30671753), National Natural Science Foundation of Guangdong (No. 06021315), and Science Technology Development Program of Guangdong (No. 2008B030301100).
###end p 84
###begin article-title 85
Global cancer statistics, 2002
###end article-title 85
###begin article-title 86
###xml 151 159 <span type="species:ncbi:9606">patients</span>
Diagnostic value and complications of fine needle aspiration for primary liver cancer and its influence on the treatment outcome-a study based on 3011 patients in China
###end article-title 86
###begin article-title 87
###xml 124 135 <span type="species:ncbi:10116">Wistar rats</span>
Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats
###end article-title 87
###begin article-title 88
###xml 41 46 <span type="species:ncbi:9606">human</span>
Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis
###end article-title 88
###begin article-title 89
c-Myc-induced genomic instability
###end article-title 89
###begin article-title 90
Disruption of circadian coordination and malignant growth
###end article-title 90
###begin article-title 91
###xml 41 47 <span type="species:ncbi:10090">murine</span>
Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis
###end article-title 91
###begin article-title 92
Targeting of Miz-1 is essential for Myc-mediated apoptosis
###end article-title 92
###begin article-title 93
###xml 138 144 <span type="species:ncbi:10090">murine</span>
Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas
###end article-title 93
###begin article-title 94
Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation
###end article-title 94
###begin article-title 95
###xml 179 183 <span type="species:ncbi:10116">rats</span>
Hypomethylation of CpG sites and c-myc gene overexpression in hepatocellular carcinomas, but not hyperplastic nodules, induced by a choline-deficient L-amino acid-defined diet in rats
###end article-title 95
###begin article-title 96
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer
###end article-title 96
###begin article-title 97
The regulation of INK4/ARF in cancer and aging
###end article-title 97
###begin article-title 98
Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma
###end article-title 98
###begin article-title 99
###xml 98 103 <span type="species:ncbi:9606">human</span>
Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis
###end article-title 99
###begin article-title 100
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Detection of aberrant p16INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma
###end article-title 100
###begin article-title 101
###xml 41 44 <span type="species:ncbi:10116">rat</span>
Selenium prevents tumor development in a rat model for chemical carcinogenesis
###end article-title 101
###begin article-title 102
###xml 41 58 <span type="species:ncbi:11103">hepatitis C virus</span>
S-Adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro
###end article-title 102
###begin article-title 103
###xml 43 46 <span type="species:ncbi:10116">rat</span>
Role of elevated S-adenosylhomocysteine in rat hepatocyte apoptosis: protection by betaine
###end article-title 103
###begin article-title 104
###xml 11 16 <span type="species:ncbi:9606">human</span>
Betaine in human nutrition
###end article-title 104
###begin article-title 105
###xml 47 51 <span type="species:ncbi:10116">rats</span>
Elevated tissue betaine contents in developing rats are due to dietary betaine, not to synthesis
###end article-title 105
###begin article-title 106
AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet
###end article-title 106
###begin article-title 107
###xml 34 37 <span type="species:ncbi:10116">rat</span>
Genetic and epigenetic changes in rat preneoplastic liver tissue induced by 2-acetylaminofluorene
###end article-title 107
###begin article-title 108
###xml 93 98 <span type="species:ncbi:9606">human</span>
TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma
###end article-title 108
###begin article-title 109
###xml 144 148 <span type="species:ncbi:10116">rats</span>
Chemoprevention of mammary tumorigenesis and chemomodulation of the antioxidative enzymes and peroxidative damage in prepubertal Sprague Dawley rats by Biochanin A
###end article-title 109
###begin article-title 110
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Dietary betaine modifies hepatic metabolism but not renal injury in rat polycystic kidney disease
###end article-title 110
###begin article-title 111
###xml 75 78 <span type="species:ncbi:10116">rat</span>
Effects of betaine on ethanol-stimulated secretion of IGF-I and IGFBP-1 in rat primary hepatocytes: Involvement of p42/44 MAPK activation
###end article-title 111
###begin article-title 112
###xml 86 89 <span type="species:ncbi:10116">rat</span>
Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication
###end article-title 112
###begin article-title 113
###xml 37 40 <span type="species:ncbi:10116">rat</span>
Betaine in sub-acute and sub-chronic rat studies
###end article-title 113
###begin article-title 114
###xml 10 24 <span type="species:ncbi:53852">Cassia fistula</span>
###xml 92 96 <span type="species:ncbi:10116">rats</span>
Effect of Cassia fistula Linn. leaf extract on diethylnitrosamine induced hepatic injury in rats
###end article-title 114
###begin article-title 115
The altered DNA methylation pattern and its implications in liver cancer
###end article-title 115
###begin article-title 116
Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer
###end article-title 116
###begin article-title 117
Conformational changes of a benzo[a]pyrene diol epoxide-N(2)-dG adduct induced by a 5'-flanking 5-methyl-substituted cytosine in a (Me)CG double-stranded oligonucleotide sequence context
###end article-title 117
###begin article-title 118
###xml 54 65 <span type="species:ncbi:10116">Wistar rats</span>
p16 hypermethylation during gastric carcinogenesis of Wistar rats by N-methyl-N'-nitro-N-nitrosoguanidine
###end article-title 118
###begin article-title 119
###xml 78 86 <span type="species:ncbi:9606">Patients</span>
Detection of Aberrant p16 Methylation in the Plasma and Serum of Liver Cancer Patients
###end article-title 119
###begin article-title 120
###xml 94 98 <span type="species:ncbi:10116">rats</span>
Effects of intravenous betaine on methionine-loading-induced plasma homocysteine elevation in rats
###end article-title 120
###begin article-title 121
Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency
###end article-title 121
###begin article-title 122
Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium
###end article-title 122
###begin article-title 123
Dietary polyphenols may affect DNA methylation
###end article-title 123
###begin article-title 124
###xml 133 136 <span type="species:ncbi:10116">rat</span>
A comparison of the effects of betaine and S-adenosylmethionine on ethanol-induced changes in methionine metabolism and steatosis in rat hepatocytes
###end article-title 124
###begin article-title 125
Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations
###end article-title 125
###begin article-title 126
Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallateInt
###end article-title 126
###begin article-title 127
Folate system correlations in DNA microarray data
###end article-title 127

